TMER1-i

N/A

Report date: 2025/02/21 16:20:28
NMEFirst In Class

Base Information

Drug NameTMER1-i
Drug Alias NameCT3001TMER1-i
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 35 inhibitors
TargetsG-protein coupled receptor 35
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCrossignal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrossignal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A